An institute employee held a lesson on the prevention of seasonal infections
14  03.2026
Teachers from comprehensive schools in the Nizhny Novgorod region took part in the educational event.
The Institute conducted an introductory tour for residents of the Federal State Budgetary Educational Institution of Higher Education "Primary Medical University" of the Ministry of Health of Russia.
11  03.2026
In order to attract talented young people to scientific research and development, events are continuing in the format of the "Open Doors to Science Day" project, announced by the President of Russia as the Decade of Science and Technology.

An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg

Home  »  Health education  »  Health education news  »  An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
Print version
An institute employee presented a report at the Virology Days 2025 forum in St. Petersburg
29  09.2025
The VI International Forum "Days of Virology 2025" was held on September 22-23, 2025.

Over 800 specialists participated in the forum. The program addressed numerous current issues in modern virology, with a strong focus on the treatment and prevention of viral infections.

A separate section of the forum was devoted to the development of new approaches to creating innovative vaccines for the prevention of infectious diseases. Viktor Vladimirovich Novikov, Head of the Immunochemistry Laboratory at the I.N. Blokhina Novosibirsk Research Institute of Epidemiology and Microbiology (Rospotrebnadzor), Honored Scientist of the Russian Federation, Professor, and Doctor of Biological Sciences, delivered a presentation at the section. In his presentation, "Chimeric Norovirus Proteins as the Basis for Antiviral Vaccines," he described our institute's new immunobiotechnological developments aimed at creating innovative vaccines. The Immunochemistry Laboratory, in collaboration with specialists from other departments at the institute, has developed a molecular platform for constructing virus-like particles based on the norovirus capsid protein. Particles constructed from chimeric recombinant proteins can serve as the antigen base for vaccines. Using the developed platform, vaccine prototypes were created for the prevention of COVID-19, norovirus, and echovirus E30, which causes viral serous meningitis.